BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G Report for Entrada Therapeutics, Inc. Common Stock (TRDA)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Entrada Therapeutics, Inc. Common Stock
Symbol: TRDA
Shares outstanding: 37,253,811 shares
Disclosed Ownership: 1,974,452 shares
Ownership: 5.3%
Form type: SCHEDULE 13G
Filing time: 04 Feb 2025, 15:45:44 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.3%	1,974,452	1,932,133	0	Spencer Fleming	Managing Director